Evaluation of the Cerebral Oxygenation With Near Infrared Spectrophotometry (NIRS) at the Hypernatremic Dehydration in Newborn
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01299428 |
Recruitment Status
: Unknown
Verified February 2011 by Zekai Tahir Burak Women's Health Research and Education Hospital.
Recruitment status was: Recruiting
First Posted
: February 18, 2011
Last Update Posted
: February 18, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HYPERNATREMIA | Device: INVOS 5100 | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 2 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Screening |
Study Start Date : | February 2011 |
Estimated Primary Completion Date : | May 2011 |
Estimated Study Completion Date : | August 2011 |

Arm | Intervention/treatment |
---|---|
Active Comparator: cerebral oxygenation |
Device: INVOS 5100
INVOS 5100 IS AN EQUIPMENT THAT MEASURED CEREBRAL OXYGENATION WITH NEAR INFRARED SPECTROPHOTOMETRY METHOD.
|
- CEREBRAL OXYGENATION [ Time Frame: 3 MONTHS ]NIRS METHODS
- NEURODEVELOPMENT [ Time Frame: 12-18 MONTHS ]NEURODEVELOPMENT EVALUATION

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 1 Month (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- gestation week > 37 ve Na >150 mg/dl
- Dehydration
Exclusion Criteria:
- Sepsis
- Intracranial Haemorrhagia
- Congenital Cardiac Diseases

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01299428
Contact: melek akar, M.D | +905052550518 | melek_akar@yahoo.com.tr |
Turkey | |
Zekai Tahir Burak Maternity Teaching Hospital | Recruiting |
Ankara, Samanpazarı, Turkey, 06460 | |
Contact: melek akar, M.D. +905052550518 melek_akar@yahoo.com.tr |
Responsible Party: | Zekai Tahir Burak Maternity Teaching Hospital |
ClinicalTrials.gov Identifier: | NCT01299428 History of Changes |
Other Study ID Numbers: |
5 |
First Posted: | February 18, 2011 Key Record Dates |
Last Update Posted: | February 18, 2011 |
Last Verified: | February 2011 |
Keywords provided by Zekai Tahir Burak Women's Health Research and Education Hospital:
CEREBRAL OXYGENATION HYPERNATREMİA NEWBORN NA VALUES |
Additional relevant MeSH terms:
Hypernatremia Water-Electrolyte Imbalance Metabolic Diseases |